The impact of lipid-based nutrient supplementation on anti-malarial antibodies in pregnant women in a randomized controlled trial

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Chandrasiri, Upeksha P ^a   Fowkes, Freya J I ^a,b,c   Richards, Jack S ^a,b   Langer, Christine ^b   Fan, Yue Mei ^d,e   Taylor, Steve M ^f,g   Beeson, James G ^a,b   Dewey, Kathryn G ^h   Maleta, Kenneth ⁱ   Ashorn, Per ^d,e   Rogerson, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BURNET INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g University of North Carolina at Chapel Hill   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF MALAWI   (Malawi)

Author keywords

body mass index; immunoglobulin G isotypes; Malaria in pregnancy; Malawi; merozoite antigens; nutrient supplements; opsonizing antibodies; placental binding parasite isolate; socioeconomic status; variant surface antigens

Indexed keywords

ANTIGEN; FOLIC ACID; IMMUNOGLOBULIN G; IRON; MALARIAL ANTIBODY; OPSONIN; PARASITE ANTIBODY; PLACENTAL BINDING ANTIGEN; TRACE ELEMENT; UNCLASSIFIED DRUG; PROTOZOON ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BODY MASS; CHILD DEVELOPMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GESTATION PERIOD; HUMAN; IMMUNITY; INFECTION SENSITIVITY; LIPID BASED NUTRIENT SUPPLEMENT; MALAWI; MALNUTRITION; MEROZOITE; NUTRIENT; PARASITE ISOLATION; PREGNANCY OUTCOME; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; SCHIZONT; SOCIAL STATUS; ADAPTIVE IMMUNITY; ADOLESCENT; ANALYSIS; BLOOD; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; IMMUNOLOGY; LIPID METABOLISM; MALARIA; METABOLISM; PARASITOLOGY; PLASMODIUM; PREGNANCY; YOUNG ADULT;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HUMANS; IRON; LIPID METABOLISM; MALARIA; MALAWI; MEROZOITES; MICRONUTRIENTS; PLASMODIUM; PREGNANCY; PREGNANCY OUTCOME; SCHIZONTS; YOUNG ADULT;

EID: 84930629519     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0707-2     Document Type: Article

References (45)

1. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010;7:e1000221.
2. UNSCN. Fourth report on the world nutrition situation: nutrition throughout the life cycle. Geneva: United Nations Administrative Committee on Coordination Sub-Committee on Nutrition, (ACC/SCN); 2000.
3. Kalanda BF, Verhoeff FH, Chimsuku L, Harper G, Brabin BJ. Adverse birth outcomes in a malarious area. Epidemiol Infect. 2006;134:659-66.
4. Landis SH, Lokomba V, Ananth CV, Atibu J, Ryder RW, Hartmann KE, et al. Impact of maternal malaria and under-nutrition on intrauterine growth restriction: a prospective ultrasound study in Democratic Republic of Congo. Epidemiol Infect. 2009;137:294-304.
5. McGregor IA. Malaria: nutritional implications. Rev Infect Dis. 1982;4:798-804.
6. Shankar AH. Nutritional modulation of malaria morbidity and mortality. J Infect Dis. 2000;182 Suppl 1:S37-53.
7. Illingworth J, Butler NS, Roetynck S, Mwacharo J, Pierce SK, Bejon P, et al. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J Immunol. 2013;190:1038-47.
8. Enwere GC, Ota MO, Obaro SK. The host response in malaria and depression of defence against tuberculosis. Ann Trop Med Parasitol. 1999;93:669-78.
9. Williamson WA, Greenwood BM. Impairment of the immune response to vaccination after acute malaria. Lancet. 1978;1:1328-9.
10. Keusch GT. Immune function in the malnourished host. Pediatr Ann. 1982;11:1004-14.
11. Haller L, Zubler RH, Lambert PH. Plasma levels of complement components and complement haemolytic activity in protein-energy malnutrition. Clin Exp Immunol. 1978;34:248-52.
12. Savino W, Dardenne M. Nutritional imbalances and infections affect the thymus: consequences on T-cell-mediated immune responses. Proc Nutr Soc. 2010;69:636-43.
13. Duffy PE. Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia. Parasitology. 2007;134:1877-81.
14. Imdad A, Bhutta ZA. Maternal nutrition and birth outcomes: effect of balanced protein-energy supplementation. Paediatr Perinat Epidemiol. 2012;1:178-90.
15. Brough L, Rees GA, Crawford MA, Morton RH, Dorman EK. Effect of multiple-micronutrient supplementation on maternal nutrient status, infant birth weight and gestational age at birth in a low-income, multi-ethnic population. Br J Nutr. 2010;104:437-45.
16. Huybregts L, Roberfroid D, Lanou H, Menten J, Meda N, Van Camp J, et al. Prenatal food supplementation fortified with multiple micronutrients increases birth length: a randomized controlled trial in rural Burkina Faso. Am J Clin Nutr. 2009;90:1593-600.
17. Kayira D, Bentley ME, Wiener J, Mkhomawanthu C, King CC, Chitsulo P, et al. A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr. 2012;95:759-65.
18. Chaparro CM, Dewey KG. Use of lipid-based nutrient supplements (LNS) to improve the nutrient adequacy of general food distribution rations for vulnerable sub-groups in emergency settings. Matern Child Nutr. 2010;1:1-69.
19. Flax VL, Bentley ME, Chasela CS, Kayira D, Hudgens MG, Kacheche KZ, et al. Lipid-based nutrient supplements are feasible as a breastmilk replacement for HIV-exposed infants from 24 to 48 weeks of age. J Nutr. 2013;143:701-7.
20. Iannotti LL, Dulience SJ, Green J, Joseph S, Francois J, Antenor ML, et al. Linear growth increased in young children in an urban slum of Haiti: a randomized controlled trial of a lipid-based nutrient supplement. Am J Clin Nutr. 2014;99:198-208.
21. Phuka JC, Maleta K, Thakwalakwa C, Cheung YB, Briend A, Manary MJ, et al. Complementary feeding with fortified spread and incidence of severe stunting in 6- to 18-month-old rural Malawians. Arch Pediatr Adolesc Med. 2008;162:619-26.
22. Cox SE, Staalsoe T, Arthur P, Bulmer JN, Tagbor H, Hviid L, et al. Maternal vitamin A supplementation and immunity to malaria in pregnancy in Ghanaian primigravids. Trop Med Int Health. 2005;10:1286-97.
23. Ashorn P, Alho L, Ashorn U, Cheung YB, Dewey KG, Harjunmaa U, et al. The impact of lipid-based nutrient supplement provision to pregnant women on newborn size in rural Malawi: a randomized controlled trial. Am J Clin Nutr. 2015;101:387-97.
24. iLiNS Project Research. [ http://ilins.org/ilins-project-research/protocols ]
25. Rantala AM, Taylor SM, Trottman PA, Luntamo M, Mbewe B, Maleta K, et al. Comparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women. Malar J. 2010;9:269.
26. Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, et al. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun. 2009;77:1165-74.
27. Richards JS, Stanisic DI, Fowkes FJI, Tavul L, Dabod E, Thompson JK, et al. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis. 2010;51:e50-60.
28. Reiling L, Richards JS, Fowkes FJI, Barry AE, Triglia T, Chokejindachai W, et al. Evidence That the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. J Immunol. 2010;185:6157-67.
29. Persson KE, McCallum FJ, Reiling L, Lister NA, Stubbs J, Cowman AF, et al. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest. 2008;118:342-51.
30. Duffy MF, Byrne TJ, Elliott SR, Wilson DW, Rogerson SJ, Beeson JG, et al. Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype. Mol Microbiol. 2005;56:774-88.
31. Beeson JG, Brown GV. Plasmodium falciparum-infected erythrocytes demonstrate dual specificity for adhesion to hyaluronic acid and chondroitin sulfate A and have distinct adhesive properties. J Infect Dis. 2004;189:169-79.
32. Chandrasiri UP, Randall LM, Saad AA, Bashir AM, Rogerson SJ, Adam I. Low antibody levels to pregnancy-specific malaria antigens and heightened cytokine responses associated with severe malaria in pregnancy. J Infect Dis. 2014;209:1408-17.
33. Ataide R, Hasang W, Wilson DW, Beeson JG, Mwapasa V, Molyneux ME, et al. Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria. PLoS One. 2010;5, e10807.
34. Teo A, Hasang W, Randall LM, Feng G, Bell L, Unger H, et al. Decreasing malaria prevalence and its potential consequences for immunity in pregnant women. J Infect Dis. 2014;210:1444-55.
35. Aitken EH, Mbewe B, Luntamo M, Maleta K, Kulmala T, Friso M, et al. Antibodies to chondroitin sulfate a-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment. J Infect Dis. 2010;201:1316-25.
36. Ataide R, Mwapasa V, Molyneux ME, Meshnick SR, Rogerson SJ. Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes. PLoS One. 2011;6, e22491.
37. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. Maternal antibodies block malaria. Nature. 1998;395:851-2.
38. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Demography. 2001;38:115-32.
39. Feng G, Aitken E, Yosaatmadja F, Kalilani L, Meshnick SR, Jaworowski A, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. J Infect Dis. 2009;200:299-306.
40. Hill DL, Eriksson EM, Li Wai Suen CS, Chiu CY, Ryg-Cornejo V, Robinson LJ, et al. Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria. PLoS One. 2013;8, e74627.
41. Osier FH, Feng G, Boyle MJ, Langer C, Zhou J, Richards JS, et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria. BMC Med. 2014;12:108.
42. Doritchamou J, Bertin G, Moussiliou A, Bigey P, Viwami F, Ezinmegnon S, et al. First-trimester Plasmodium falciparum infections display a typical "placental" phenotype. J Infect Dis. 2012;206:1911-9.
43. Fowkes FJ, McGready R, Cross NJ, Hommel M, Simpson JA, Elliott SR, et al. New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J Infect Dis. 2012;206:1612-21.
44. Taylor SM, Antonia AL, Harrington WE, Goheen MM, Mwapasa V, Chaluluka E, et al. Independent lineages of highly sulfadoxine-resistant Plasmodium falciparum haplotypes, eastern Africa. Emerg Infect Dis. 2014;20:1140-8.
45. Gutman J, Kalilani L, Taylor S, Zhou Z, Wiegand RE, Thwai KL, et al. The A581G mutation in the gene encoding Plasmodium falciparum dihydropteroate synthetase reduces the effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women. J Infect Dis. 2015, 6. [Epub ahead of print].